1,349
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Implementation of a decision aid for recognition and correction of volume alterations (Recova®) in haemodialysis patients

ORCID Icon, ORCID Icon & ORCID Icon
Pages 281-292 | Received 13 May 2020, Accepted 29 Jul 2020, Published online: 27 Aug 2020

References

  • Weiner DE, Brunelli SM, Hunt A, Schiller B, Glassock R, Maddux FW, et al. Improving clinical outcomes among hemodialysis patients: a proposal for a “volume first” approach from the chief medical officers of US dialysis providers. Am J Kidney Dis. 2014;64:685–95. doi:10.1053/j.ajkd.2014.07.003
  • Sinha AD, Agarwal R. Setting the dry weight and its cardiovascular implications. Semin Dial. 2017;30:481–8. doi:10.1111/sdi.12624
  • Steinwandel U, Gibson N, Towell‐Barnard A, Parsons R, Rippey J, Rosman J. Does the intravascular volume status in haemodialysis patients measured by inferior vena cava ultrasound correlate with bioimpedance spectroscopy? J Clin Nurs. 2019;28:2135–46. doi:10.1111/jocn.14804
  • Scotland G, Cruickshank M, Jacobsen E, Cooper D, Fraser C, Shimonovich M, et al. Multiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systematic review and economic evaluation. Health Technol Assess. 2018;22:1–138. doi:10.3310/hta22010
  • Wabel P, Chamney P, Moissl U, Jirka T. Importance of whole-body bioimpedance spectroscopy for the management of fluid balance. Blood Purif. 2009;27:75–80. doi:10.1159/000167013
  • Hur E, Usta M, Toz H, Asci G, Wabel P, Kahvecioglu S, et al. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis. 2013;61:957–65. doi:10.1053/j.ajkd.2012.12.017
  • Onofriescu M, Hogas S, Voroneanu L, Apetrii M, Nistor I, Kanbay M, et al. Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis. 2014;64:111–8. doi:10.1053/j.ajkd.2014.01.420
  • Ok E, Levin NW, Asci G, Chazot C, Toz H, Ozkahya M. Interplay of volume, blood pressure, organ ischemia, residual renal function, and diet: certainties and uncertainties with dialytic management. Semin Dial. 2017;30:420–9. doi:10.1111/sdi.12612
  • Reeves PB, Mc Causland FR. Mechanisms, clinical implications, and treatment of intradialytic hypotension. Clin J Am Soc Nephrol. 2018;13:1297–303. doi:10.2215/CJN.12141017
  • Covic A, Ciumanghel A-I, Siriopol D, Kanbay M, Dumea R, Gavrilovici C, et al. Value of bioimpedance analysis estimated “dry weight” in maintenance dialysis patients: a systematic review and meta-analysis. Int Urol Nephrol. 2017;49:2231–45. doi:10.1007/s11255-017-1698-4
  • Beaubien-Souligny W, Kontar L, Blum D, Bouchard J, Denault AY, Wald R. Meta-analysis of randomized controlled trials using tool-assisted target weight adjustments in chronic dialysis patients. Kidney Int Rep. 2019;4:1426–34. doi:10.1016/j.ekir.2019.07.003
  • Tabinor M, Davies SJ. The use of bioimpedance spectroscopy to guide fluid management in patients receiving dialysis. Curr Opin Nephrol Hypertens. 2018;27:406–12. doi:10.1097/MNH.0000000000000445
  • Dekker MJE, Kooman JP. Fluid status assessment in hemodialysis patients and the association with outcome: review of recent literature. Curr Opin Nephrol Hypertens. 2018;27:188–93. doi:10.1097/MNH.0000000000000409
  • Stenberg J, Lindberg M, Furuland H. Clinical praxis for assessment of dry weight in Sweden and Denmark: a mixed-methods study. Hemodial Int. 2016;20:111–9. doi:10.1111/hdi.12336
  • Dasgupta I, Thomas GN, Clarke J, Sitch A, Martin J, Bieber B, et al. Associations between hemodialysis facility practices to manage fluid volume and intradialytic hypotension and patient outcomes. Clin J Am Soc Nephrol. 2019;14:385–93. doi:10.2215/CJN.08240718
  • Dasgupta I, Farrington K, Davies SJ, Davenport A, Mitra S. UK national survey of practice patterns of fluid volume management in haemodialysis patients: a need for evidence. Blood Purif. 2016;41:324–31. doi:10.1159/000444246
  • Stenberg J, Keane D, Lindberg M, Furuland H. Systematic fluid assessment in haemodialysis: development and validation of a decision aid. J Ren Care. 2020;46:52–61. doi:10.1111/jorc.12304
  • Siriopol I, Siriopol D, Voroneanu L, Covic A. Predictive abilities of baseline measurements of fluid overload, assessed by bioimpedance spectroscopy and serum N-terminal pro-B-type natriuretic peptide, for mortality in hemodialysis patients. Arch Med Sci. 2017;13:1121–9. doi:10.5114/aoms.2017.68993
  • Chamney PW, Wabel P, Moissl UM, Müller MJ, Bosy-Westphal A, Korth O, et al. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr. 2007;85:80–9. doi:10.1093/ajcn/85.1.80
  • Passauer J, Petrov H, Schleser A, Leicht J, Pucalka K. Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy: a cross-sectional study. Nephrol Dial Transplant. 2010;25:545–51. doi:10.1093/ndt/gfp517
  • Wabel P, Moissl U, Chamney P, Jirka T, Machek P, Ponce P, et al. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant. 2008;23:2965–71. doi:10.1093/ndt/gfn228
  • Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2016;25:986–92. doi:10.1136/bmjqs-2015-004411
  • Dekker MJE, Marcelli D, Canaud BJ, Carioni P, Wang Y, Grassmann A, et al.; MONDO Initiative. Impact of fluid status and inflammation and their interaction on survival: a study in an international hemodialysis patient cohort. Kidney Int. 2017;91:1214–23. doi:10.1016/j.kint.2016.12.008
  • Chen H, Wu B, Gong D, Liu Z. Fluid overload at start of continuous renal replacement therapy is associated with poorer clinical condition and outcome: a prospective observational study on the combined use of bioimpedance vector analysis and serum N-terminal pro-B-type natriuretic peptide measurement. Crit Care. 2015;19:135. doi:10.1186/s13054-015-0871-3
  • Antlanger M, Josten P, Kammer M, Exner I, Lorenz-Turnheim K, Eigner M, et al. Blood volume-monitored regulation of ultrafiltration to decrease the dry weight in fluid-overloaded hemodialysis patients: a randomized controlled trial. BMC Nephrol. 2017;18:238. doi:10.1186/s12882-017-0639-x
  • McIntyre CW, Salerno FR. Diagnosis and treatment of intradialytic hypotension in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2018;13:486–9. doi:10.2215/CJN.11131017
  • Kim EJ, Choi MJ, Lee JH, Oh JE, Seo JW, Lee YK, et al. Extracellular fluid/intracellular fluid volume ratio as a novel risk indicator for all-cause mortality and cardiovascular disease in hemodialysis patients. PLoS One. 2017;12:e0170272. doi:10.1371/journal.pone.0170272
  • Dekker MJE, Konings C, Canaud B, van der Sande FM, Stuard S, Raimann JG, et al. Interactions between malnutrition, inflammation, and fluid overload and their associations with survival in prevalent hemodialysis patients. J Ren Nutr. 2018;28:435–44. doi:10.1053/j.jrn.2018.06.005
  • Ohashi Y, Sakai K, Hase H, Joki N. Dry weight targeting: the art and science of conventional hemodialysis. Semin Dial. 2018;31:551–6. doi:10.1111/sdi.12721
  • Patel HV, Annigeri RA, Kowdle PC, Rao BS, Seshadri R, Balasubramanian S, et al. Bioimpedance spectroscopy-guided ultrafiltration normalizes hydration and reduces intradialytic adverse events in hemodialysis patients. Indian J Nephrol. 2019;29:1–7.
  • Agarwal R. B-type natriuretic peptide is not a volume marker among patients on hemodialysis. Nephrol Dial Transplant. 2013;28:3082–9. doi:10.1093/ndt/gft054
  • Mahmood U, Johnson DW, Fahim MA. Cardiac biomarkers in dialysis. AIMS Genet. 2017;4:1–20. doi:10.3934/genet.2017.1.1